Boston, MA, United States of America

Isabelle Rivière


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Isabelle Rivière

Introduction: Isabelle Rivière is a notable inventor based in Boston, MA, known for her groundbreaking contributions to retroviral gene therapy. With a focus on enhancing therapeutic methods, she has made significant strides in the field of genetic medicine. Her innovative approach has the potential to impact various disease states, paving the way for advanced treatment possibilities.

Latest Patents: Isabelle Rivière holds one patent titled "Retroviral Gene Therapy Vectors and Therapeutic Methods Based Thereon." This patent details retroviral vectors that include an insertion site for genes of interest, allowing for the high-level expression of therapeutic proteins across diverse transfected cell types. Additionally, the vectors are designed without a selectable marker, making them suitable for human gene therapy while eliminating the co-expression of marker products such as antibiotics. These retroviral vectors are particularly advantageous for use in specific packaging cell lines, underscoring her innovative approach to gene therapy solutions.

Career Highlights: Throughout her career, Isabelle has demonstrated a commitment to advancing medical science through her research and development efforts. Her pioneering work in gene therapy has positioned her as a respected figure in her field, with a focus on producing effective therapeutic solutions for patients.

Collaborations: Isabelle Rivière has collaborated with notable colleagues, including Lawrence K. Cohen and Brad Guild. These partnerships have facilitated the growth and expansion of her research initiatives, leading to significant advancements in their shared areas of expertise.

Conclusion: Isabelle Rivière's contributions in the realm of retroviral gene therapy highlight her role as a trailblazer in the industry. Her patent work and collaborative efforts solidify her status as an impactful inventor, ensuring that her innovations will continue to shape the future of genetic medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…